Job Specifications
Location of role Oxford, UK
Department Clinical Development
Key Responsibilities Purpose of the role
This project will involve the student learning and applying both basic and complex immunohistochemistry (IHC) techniques, with the potential to incorporate immunofluorescent staining or in-situ hybridisation. The student will receive comprehensive training to develop expected competencies in critical areas such as working to Human Tissue Act (2004) guidelines, compliance with Good Clinical Practise (GCP), microtomy, automated and manual staining methods, whole-slide scanning, and molecular methods where appropriate. The student will work closely with all members of the Translational Medicine Exploratory Diagnostics team, allowing them to develop skills in tissue handling and learn all technical aspects of their project.
The student will receive training in the histological characterisation of human and/or animal tissue, developing an in-depth knowledge of digital pathology techniques to support advanced analysis. This may include training or utilising AI algorithms and spatial analysis workflows to enhance analytical capabilities.
The student will actively contribute to optimising and validating IHC assays, including multiplex panels, which will be applied to both research and clinical trial samples.
In a project-specific context, the student will gain experience in designing, preparing, and running experiments. Throughout this placement, the student will have the opportunity to collaborate with members of other teams to combine data generated from multiple sources. This will involve generating and processing data, followed by biologically interpreting these findings to understand the relevance of specific biomarkers to patient outcomes within clinical trials, with opportunities to present these insights to the team or wider Translational Medicine department.
Key Responsibilities
Handle and process human tissue, following HTA guidelines and GCP compliance where appropriate.
Optimise, validate, and perform immunohistochemical analysis on research and clinical trial samples.
Perform complex digital image analysis including examination of the spatial location of immune cells within the tumour microenvironment.
Combine data generated by other labs and perform molecular techniques to support the IHC work.
Interpret the biological significance of the data generated in collaboration with data science.
Education & Qualifications
Currently studying a biology or related degree.
Strong interest in cancer biology and curiosity to uncover how the immune system and tumours interact in response to ImmTAC therapy.
Good communication skills.
Organisation and flexibility to be able to adapt to changing priorities.
Enthusiasm and willingness to learn new techniques and practices.
Diligence and maintenance of accurate records.
Ability to work co-operatively as part of a team.
Evidence of wet-lab experience is desirable.
Technical or theoretical knowledge of immunohistochemistry / histological techniques is essential.
What will you receive?
Join Immunocore for a paid placement and gain insights from our innovative science and corporate growth. You’ll enjoy 25 days of annual leave (pro rata), pension scheme eligibility, and access to our active Sports and Social Club with subsidized events.
Please note this is a full-time position is based at our Abingdon, Oxfordshire office and contracted through a third party.
Important information for all applicants
The application deadline is 09th January 2026, with phone interviews starting shortly after. Shortlisted candidates will be invited to an in-person Assessment Centre on 23rd, 24th, 25th, or 26th February 2026, providing an opportunity to meet current placement students, learn about the role, and socialize with employees.
Placements are expected to begin on 7th September 2026.
Please note - should you not be available on all the above dates, unfortunately, we won't be able to proceed with your application.
If interested, apply with your CV and a cover letter (combined in one document) stating your main areas of interest.
About the Company Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry’s most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.
Focused on delivering first-in-class biological therapies to patients, we have developed a highly innovative soluble TCR platform. Our ImmTAX molecules underpin a new generation of precision engineered drugs that harness the immune system to treat a broad spectrum of diseases with high unmet medical n